America’s Fentanyl Epidemic: The China Connection

Over the past few years, a new threat has emerged as a leading cause of death in the United States: fentanyl. Yet even as the drug wreaks havoc on Americans lives, preventing its flow into the United States is complicated, partially because of the supply’s overseas origins, which is often China. What is China’s role in the U.S. fentanyl crisis?

Play Button Pause Button
0:00 0:00
x
Host
  • Gabrielle Sierra
    Director, Podcasting
Credits

Asher Ross - Supervising Producer

Markus Zakaria - Audio Producer and Sound Designer

Molly McAnany - Associate Podcast Producer

Episode Guests
  • Thomas J. Bollyky
    Bloomberg Chair in Global Health; Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program
  • Zongyuan Zoe Liu
    Maurice R. Greenberg Senior Fellow for China Studies
  • Shannon K. O'Neil
    Senior Vice President, Director of Studies, and Maurice R. Greenberg Chair

Show Notes

The prolonged opioid epidemic has become the worst drug crisis in U.S. history. Its modern era has been defined by fentanyl, a synthetic opioid that is cheap to make and deadly to consume, even in small doses.

 

China is the primary manufacturer of the ingredients to make fentanyl, which often go to Mexican cartels that smuggle most of the fentanyl that reaches the United States across the southern U.S. border. While China has made some efforts to restrict fentanyl production, more Americans died from drug overdoses in 2022 than ever before, and the majority of those overdoses involved fentanyl or a similar drug. Meanwhile, geopolitical competition between Washington and Beijing has continued to heat up, and experts are pessimistic that the two will be able to cooperate on curbing the flow of fentanyl. 

 

 

From CFR

 

David P. Fidler, “Fentanyl and Foreign Policy,” Think Global Health

 

Claire Klobucista and Alejandra Martinez, “Fentanyl and the U.S. Opioid Epidemic”

 

CFR.org Editors, "Mexico's Long War: Drugs, Crime, and the Cartels"

 

 

From Our Guests


Reporting on Fentanyl and the Opioid Crisis,” CFR Events

 

 

Read More

 

Vanda Felbab-Brown, “China’s Role in the Fentanyl Crisis,” Brookings

 

Sadie Gurman, “Biden Administration Indicts Chinese Firms Allegedly Tied to Fentanyl Distribution,” Wall Street Journal

 

Horrifying Numbers of Americans Will Not Make it to Old Age,” The Economist

 

Shannon K. O’Neil, “The Western Hemisphere Drug Policy Commission: Charting a New Path Forward” [PDF], U.S. Drug Policy in Latin America and the Caribbean, House Foreign Affairs Committee

 

 

Watch and Listen

 

China’s Role in the Smuggling of Synthetic Drugs and Precursors,” Brookings

 

Why the U.S. Is Pressuring China Amid a Crackdown on the Global Fentanyl Trade,” PBS News Weekend

Trade

With allies and adversaries alike impacted by new economic barriers and tariffs, the global map of U.S. trade relationships hangs in question. As the U.S. rethinks its commitments with its trading partners, allies may seek deals elsewhere, even with historic rivals. Can the president single-handedly tear up a trade deal, and what happens when deals that took decades to craft are suddenly up for renegotiation?

Trade

Tariffs have sparked intense debate in Washington, but their consequences land far from Capitol Hill. Tariffs can shape paychecks, shift prices for consumers, and affect markets. At best, tariffs offer short-term protection for certain industries. At worst, they can uproot the lives of American workers. In this episode, Why It Matters looks at what tariffs mean for a U.S. steel manufacturer and small business owner trying to stay afloat.

Trade

Tariffs are often discussed in big, abstract terms—trade wars, economic strategy, global power struggles. But for ginseng farmers in Wisconsin, their effects are painfully personal. In this episode, Why It Matters dives into how tariffs work and how they’re hitting one of America's most niche yet lucrative exports: Wisconsin-grown ginseng.

Top Stories on CFR

Asia

U.S.-China trade talks in Geneva resulted in a temporary slash of tariff rates, but the ripple effect of this tit-for-tat escalation won’t disappear anytime soon.

Iran

Karim Sadjadpour, senior fellow at the Carnegie Endowment for International Peace, sits down with James M. Lindsay to discuss the ongoing talks between the United States and Iran over Iran’s nuclear program.

Economics

Speeding trusted investment from allies and partners would strengthen U.S. competitiveness and security.